Interval breast cancer is associated with interferon immune response-Reference-Cited by-同舟云学术

Interval breast cancer is associated with interferon immune response

Published:2022-02 Issue: Volume:162 Page:194-205
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ugalde-Morales Emilio^ORCID,Grassmann Felix,Humphreys Keith,Li Jingmei^ORCID,Eriksson Mikael^ORCID,Tobin Nicholas P.^ORCID,Lindström Linda S.,Vallon-Christersson Johan,Borg Åke,Hall Per,Czene Kamila

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Biologic characteristics of interval and screen-detected breast cancers;Gilliland;J Natl Cancer Inst,2000

2. Breast cancer with a poor prognosis diagnosed after screening mammography with negative results;McCarthy;JAMA Oncol,2018

3. Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study;Rayson;Clin Breast Cancer,2011

4. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program;Kirsh;J Natl Cancer Inst,2011

5. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers;Porter;J Natl Cancer Inst,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin prevents colorectal cancer by regulating the abundance of Enterococcus cecorum and TIGIT+Treg cells;Scientific Reports;2024-06-12

2. The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk;British Journal of Cancer;2023-12-22

3. Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer;Asian Journal of Surgery;2023-09

4. Advances in Breast Cancer Screening: Precision, Imaging, and Harms;Screening and Risk Reduction Strategies for Breast Cancer;2023